期刊
CARDIOVASCULAR RESEARCH
卷 73, 期 4, 页码 657-666出版社
OXFORD UNIV PRESS
DOI: 10.1016/j.cardiores.2006.12.009
关键词
calmodulin kinase II; arrhythmias
资金
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062494, R01HL096652, P01HL046681, R01HL070250] Funding Source: NIH RePORTER
- NHLBI NIH HHS [HL62494, R01 HL096652, HL070250, HL046681] Funding Source: Medline
The multifunctional Ca2+ calmodulin-dependent protein kinase II (CaMKII) has emerged as a pro-arrhythmic signaling molecule. CaMKII can participate in arrhythmia signaling by effects on ion channel proteins, intracellular Ca2+ uptake and release, regulation of cell death, and by activation of hypertrophic signaling pathways. The pleuripotent nature of CaMKII is reminiscent of another serine-threonine kinase, protein kinase A (PKA), which shares many of the same protein targets and is the downstream kinase most associated with beta-adrenergic receptor stimulation. The ability of CaMKII to localize and coordinate activity of multiple protein targets linked to Ca2+ signaling set CaMKII apart from other traditional arrhythmia drug targets, such as ion channel proteins. This review will discuss some of the biology of CaMKII and focus on work that has been done on molecular, cellular, and whole animal models that together build a case for CaMKII as a pro-arrhythmic signal and as a potential therapeutic target for arrhythmias and structural heart disease. (c) 2007 European Society of Cardiology. Published by Elsevier B.V All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据